Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Cyclometallated iridium(iii) complexes: ligand-driven selectivity for chemotherapy and photodynamic therapy

  • Morales-Pioz, Eva
  • Redrado, Marta
  • Benedi, Andrea
  • Aquino, Araceli de
  • García-Orduña, Pilar
  • Royo-Cañas, María
  • Godino, Javier
  • Marzo, Isabel
  • Rodríguez, Laura
  • Gimeno, M. Concepción
  • Fernández-Moreira, Vanesa
This article is part of the themed collection: Photodynamic Therapy (PDT)., This study explores two cyclometallated Ir(III) complex families with distinct therapeutic profiles. Benzothiophene derivatives (1, 2) exhibit potent antiproliferative character in the dark, favoring chemotherapy, while benzothiazole analogs (3 and 4) show high photocytotoxicity, ideal for photodynamic therapy. Photophysical studies and subcellular localization analyses highlight ligand-driven selectivity and the role of organelle targeting in therapeutic outcomes., This work was supported by projects PID2022-137862NB-I00, PID2022-136861NB-I00, and PID2022-139296NB-I00, funded by MICIU/AEI/10.13039/501100011033 and the European Union; CNS2023-143600 (MICIU/AEI and NextGenerationEU/PRTR); and COST Action CA22131, LUCES. Financial support from the Gobierno de Aragón–Fondo Social Europeo (E07_23R) and the Spanish network OASIS (RED2022-134074-T) is also acknowledged. M. R. gratefully acknowledges the Fondation pour la Recherche Médicale (FRM, SPF202309017545)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Exploring the structure–property relationship in montmorillonite–carbon quantum hybrid nanomaterials

  • Cutrim, Elaine S. M.
  • Figueredo, Aline S.
  • Silva, Lucilene A.
  • Fernández-Moreira, Vanesa
  • Alcântara, Ana C. S.
Data is available on request from the authors due to privacy., Combining montmorillonite (MMT), a layered silicate clay, with carbon quantum dots (CQD) is a promising strategy to develop hybrid nanomaterials with enhanced and tunable properties. In this work, we explore the structure–property relationships in montmorillonite–carbon quantum dot (MCQD) hybrid nanomaterials synthesized through two distinct routes. In Route 1, pre-synthesized CQDs using citric acid and urea as precursors were physically mixed with MMT, giving rise to MCQD-R1 hybrid nanomaterials. In Route 2, MMT was added in situ in the CQD reaction medium before thermal treatment, with contact times from 1 to 16 h, generating MCQD-R2-1 and MCQD-R2-16, respectively. Structural and spectroscopy techniques were employed to investigate the resulting hybrids. PXRD analysis revealed that the synthesis conditions preserved the crystalline structures of both CQD and MMT clay. The FT-IR indicated that in the MCQD-R1, the interactions with CQD occur primarily via the interlayer water molecules in MMT, whereas in the MCQD-R2-16 samples, the establishment of new chemical bonds involving the carbonyl group of CQD takes place. UV-Vis spectroscopy shows improved colloidal stability of MCQD-R2 hybrids compared to pristine CQDs. Finally, hemolysis assays demonstrated hemolytic activity below 5%, indicating good biocompatibility of the synthesized hybrid nanomaterials., This work was supported by the financial support of Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, CAPES (Finance code 001 and PROCAD-Amazonia), FAPEMA (UNIVERSAL-06741/22) and CNPq (315109/2021–1; 311112/2025-0). Project PID2022-137862NB-I00 was funded by MICIU/AEI/10.13039/501100011033 and project CNS2023-143600 was funded by MICIU/AEI/10.13039/501100011033 and European Union NextGenerationEU/PRTR., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Structure–activity insights into benzimidazole-based Ir(iii) cyclometallated complexes for cancer therapy

  • Morales-Pioz, Eva
  • Martínez, Mónica
  • Benedi, Andrea
  • Tejera-Ruiz, María
  • Marzo, Isabel
  • Gimeno, M. Concepción
  • Vázquez-López, Ezequiel M.
  • García-Fontán, Soledad
  • Fernández-Moreira, Vanesa
A family of cyclometallated Ir(III) complexes incorporating benzimidazole-based C^N ligands and ancillary diimines with distinct functionalities, 2-(pyridin-2-yl)-1H-benzo[d]imidazole (L1), 4-(1H-benzo[d]imidazol-2-yl)thiazole (L2), di(pyridin-2-yl)amine (L3), [2,2′-bipyridine]-4,4′-dicarboxylic acid (L4), and dibutyl[2,2′-bipyridine]-4,4′-dicarboxylate (L5), has been synthesised. All complexes display oxygen-sensitive emission in the 477–695 nm range; however, singlet oxygen (1O2) generation, detected by fluorescence spectroscopy, was only observed for complexes 1, 4, and 5, which exhibit non-structured emission bands associated with 3MLCT and 3LLCT transitions. In contrast, complexes 2 and 3 show structured emission profiles consistent with predominant 3LC character. The complexes exhibit distinct antitumour activity in A549 cells depending on the nature of the ancillary ligand. Complex 3, bearing an exocyclic amine donor, displayed efficient cellular uptake and significant dark cytotoxicity. Complexes 1 and 2, featuring endocyclic benzimidazole donors, showed lower cellular accumulation and no activity in the dark. A similar trend was observed for complex 4, while complex 5, its esterified analogue, showed remarkable chemotherapeutic activity and high cell uptake. The different pKa values of 2, 3 and 4 further correlate with their internalization capacity. Upon light irradiation, complexes 2, 3, and 5 exhibited enhanced antiproliferative effects and induced apoptotic cell death, probably through reactive oxygen species (ROS) generation as indicated by flow cytometry. Nevertheless, only complex 2 retained phototherapeutic potential due to its low dark toxicity. Mechanistic studies revealed that complex 2 is capable of oxidising NADH under irradiation and generating H2O2. Overall, these results reveal clear structure–activity relationships and highlight complex 2 as a promising candidate for photodynamic therapy (PDT), while complexes 3 and 5 act predominantly as chemotherapeutic-like agents., Authors thank grant PID2022-137862NB-I00 and PID2022-136861NB-I00 funded by MICIU/AEI/10.13039/501100011033 and by the European Union; grant CNS2023-143600 funded by MCINU/AEI/10.13039/501100011033 and by the European Union NextGenerationEU/PRTR. Authors also thank the Gobierno de Aragón-Fondo Social Europeo (E07_23R) and Xunta de Galicia (GRC-ED431C 2024/28) for financial support and the Spanish network OASIS (RED2022-134074-T) is also acknowledged., Peer reviewed
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Ligand engineering enables efficient intracellular chemiluminescence-driven activation of luminol-functionalised Ir(iii) complexes

  • Morales-Pioz, Eva
  • Redrado, Marta
  • Mesdom, Pierre
  • Pedrón, Manuel
  • Salluce, Giulia
  • Gasser, Gilles
  • Fernández-Moreira, Vanesa
Cyclometalated Ir(iii) complexes are promising photosensitisers (PSs) for photodynamic therapy (PDT), yet their dependence on external light remains a major limitation for the treatment of deep or poorly accessible tumours. Here, we report on a modular chemiluminescence-activated PDT platform based on luminol-functionalised Ir(iii) complexes capable of undergoing chemiluminescence resonance energy transfer (CRET) without external light irradiation. A systematic 2 × 2 ligand matrix combining two cyclometalating C^N ligands and two electronically distinct N^N ligands was developed to elucidate the influence of ligand design on excited-state properties, CRET efficiency, and biological activity. Photophysical studies revealed that cyclometalated ligand scaffolds strongly influence excited-state localisation and emission behaviour, with luminol conjugation inducing substantial reorganisation of the emissive states in selected metal complexes. Excitation–emission mapping, spectral overlap analysis, and TD-DFT calculations support efficient intramolecular energy transfer between luminol-derived chemiluminescence and the Ir(iii) PS, particularly for the phenylbenzothiazole-based derivatives. Biological evaluation demonstrated negligible dark toxicity together with efficient photoinduced cytotoxicity upon 450 nm irradiation. Importantly, luminol-functionalised metal complexes exhibited significant intracellular activation under chemiluminescent conditions, whereas the corresponding non-luminol analogues remained inactive, confirming the essential role of the luminol unit in CRET-mediated activation. Mechanistic studies revealed ligand-dependent differences in cellular localisation, mitochondrial response, and intracellular ROS generation. The radical-based ROS profile observed under CRET conditions is consistent with a greater contribution of type I-like ROS pathways compared with conventional photoactivation. Finally, CRET-mediated activation was maintained in 3D multicellular tumour spheroids under conditions where external photoactivation showed limited effects, highlighting the potential of internally activated PDT strategies in tumour-like environments where light penetration may be challenging. Collectively, this work establishes design principles governing chemiluminescence-driven activation of metal-based PSs and demonstrates that single-luminol Ir(iii) conjugates constitute a viable molecular platform for CRET-mediated PDT.